Literature DB >> 31547688

HIV and carotid atherosclerosis: a mediational model.

Maria Luisa Alcaide1, Violeta J Rodriguez2,3, John M Abbamonte2, Suresh Pallikuth4, Jake Langlie2, Manasi Soni2, Stephen M Weiss2, Barry E Hurwitz1,5, Savita Pahwa4, Deborah L Jones2, Mahendra Kumar2.   

Abstract

Cardiovascular disease (CVD) is the leading cause of death in the US and is a significant contributor to morbidity and mortality for people living with HIV (PLWH). This study examined the association between HIV infection, cocaine usage, and inflammatory markers, and their combined association with carotid atherosclerosis among young and middle-aged adults with HIV. Participants (N = 494) were enrolled based on HIV status and cocaine use. Blood pressure, body mass index (BMI), and cocaine use were assessed. Cytokines and growth factors, IL-1a, IL-6, TNFα and VEGF, and immune activation markers, sCD14 and sCD163 were measured. Participant age was 36.2 years (SD = 9.5); 50% were male, 49% female and 1% transgender; 39% were HIV-positive, 50% were current or past smokers, and 39% endorsed cocaine use. A path analysis showed an indirect effect of HIV serostatus on the presence of carotid atherosclerotic plaques (Indirect Effect = 0.048, SE = 0.024, p = .043), when controlling age, BMI, smoking, and cocaine use. This effect was mediated by inflammatory markers and changes in blood pressure. Findings point to putative underlying mechanisms leading to atherosclerosis among PLWH.

Entities:  

Keywords:  Atherosclerosis; HIV; cocaine; immune activation; inflammation

Mesh:

Substances:

Year:  2019        PMID: 31547688      PMCID: PMC7085952          DOI: 10.1080/09540121.2019.1668527

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  12 in total

Review 1.  Bidirectional relation between inflammation and coagulation.

Authors:  Marcel Levi; Tom van der Poll; Harry R Büller
Journal:  Circulation       Date:  2004-06-08       Impact factor: 29.690

2.  Confidence Limits for the Indirect Effect: Distribution of the Product and Resampling Methods.

Authors:  David P Mackinnon; Chondra M Lockwood; Jason Williams
Journal:  Multivariate Behav Res       Date:  2004-01-01       Impact factor: 5.923

3.  Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers.

Authors:  Udo Hoffmann; Michael T Lu; Devvora Olalere; Elizabeth C Adami; Michael T Osborne; Alex Ivanov; John Sukumar Aluru; Saeyun Lee; Nadja Arifovic; Edgar Turner Overton; Carl J Fichtenbaum; Judith A Aberg; Beverly Alston-Smith; Karin L Klingman; Myron Waclawiw; Tricia H Burdo; Kenneth C Williams; Markella V Zanni; Patrice Desvigne-Nickens; Katharine Cooper-Arnold; Kathleen V Fitch; Heather Ribaudo; Pamela S Douglas; Steven K Grinspoon
Journal:  Am Heart J       Date:  2019-03-04       Impact factor: 4.749

4.  Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study.

Authors:  Veit Sandfort; David A Bluemke; Jose Vargas; Jeffrey A Brinker; Gary Gerstenblith; Thomas Kickler; Gang Zheng; Ji Li; Shaoguang Chen; Hong Lai; Elliot K Fishman; Shenghan Lai
Journal:  J Addict Med       Date:  2017 Mar/Apr       Impact factor: 3.702

5.  Chronic cocaine disrupts neurovascular networks and cerebral function: optical imaging studies in rodents.

Authors:  Qiujia Zhang; Jiang You; Nora D Volkow; Jeonghun Choi; Wei Yin; Wei Wang; Yingtian Pan; Congwu Du
Journal:  J Biomed Opt       Date:  2016-02       Impact factor: 3.170

Review 6.  Reliability of the Structured Clinical Interview for DSM-III-R: an evaluative review.

Authors:  D L Segal; M Hersen; V B Van Hasselt
Journal:  Compr Psychiatry       Date:  1994 Jul-Aug       Impact factor: 3.735

7.  Recommendations for Improving and Standardizing Vascular Research on Arterial Stiffness: A Scientific Statement From the American Heart Association.

Authors:  Raymond R Townsend; Ian B Wilkinson; Ernesto L Schiffrin; Alberto P Avolio; Julio A Chirinos; John R Cockcroft; Kevin S Heffernan; Edward G Lakatta; Carmel M McEniery; Gary F Mitchell; Samer S Najjar; Wilmer W Nichols; Elaine M Urbina; Thomas Weber
Journal:  Hypertension       Date:  2015-07-09       Impact factor: 10.190

8.  Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study.

Authors:  Maria Teresa Beires; André Silva-Pinto; Ana Cristina Santos; António José Madureira; Jorge Pereira; Davide Carvalho; António Sarmento; Paula Freitas
Journal:  BMC Infect Dis       Date:  2018-01-11       Impact factor: 3.090

Review 9.  Immunity, atherosclerosis and cardiovascular disease.

Authors:  Johan Frostegård
Journal:  BMC Med       Date:  2013-05-01       Impact factor: 8.775

10.  Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study.

Authors:  Sean G Kelly; Michael Plankey; Wendy S Post; Xiuhong Li; Ronald Stall; Lisa P Jacobson; Mallory D Witt; Lawrence Kingsley; Christopher Cox; Matthew Budoff; Frank J Palella
Journal:  PLoS One       Date:  2016-01-26       Impact factor: 3.240

View more
  3 in total

1.  Predicting cardiovascular risk using a novel risk score in young and middle-age adults with HIV: associations with biomarkers and carotid atherosclerotic plaque.

Authors:  Violeta J Rodriguez; John M Abbamonte; Manasi S Parrish; Deborah L Jones; Stephen Weiss; Suresh Pallikkuth; Michal Toborek; Maria L Alcaide; Dushyantha Jayaweera; Savita Pahwa; Tatjana Rundek; Barry E Hurwitz; Mahendra Kumar
Journal:  Int J STD AIDS       Date:  2021-11-02       Impact factor: 1.456

2.  Prevalence and correlates of carotid plaque in a mixed HIV-serostatus cohort in Uganda.

Authors:  Prossy Bibangambah; Linda C Hemphill; Moses Acan; Alexander C Tsai; Ruth N Sentongo; June-Ho Kim; Isabelle T Yang; Mark J Siedner; Samson Okello
Journal:  BMC Cardiovasc Disord       Date:  2021-12-15       Impact factor: 2.298

Review 3.  HIV-1 Tat: Role in Bystander Toxicity.

Authors:  David Ajasin; Eliseo A Eugenin
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.